145 related articles for article (PubMed ID: 35850921)
1. Letter to the editor on "Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017, parts 1-3".
Chen FY; Barnes M; Lewis EC
Arch Public Health; 2022 Jul; 80(1):172. PubMed ID: 35850921
[TBL] [Abstract][Full Text] [Related]
2. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 3 - spatiotemporal, multivariable and causal inferential pathfinding and exploratory analyses of prostate and ovarian cancers.
Reece AS; Hulse GK
Arch Public Health; 2022 Mar; 80(1):101. PubMed ID: 35354499
[TBL] [Abstract][Full Text] [Related]
3. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 2 - categorical bivariate analysis and attributable fractions.
Reece AS; Hulse GK
Arch Public Health; 2022 Mar; 80(1):100. PubMed ID: 35354495
[TBL] [Abstract][Full Text] [Related]
4. Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001-2015.
Reece AS; Hulse GK
BMC Pediatr; 2022 Jan; 22(1):47. PubMed ID: 35042455
[TBL] [Abstract][Full Text] [Related]
5. Geotemporospatial and causal inferential epidemiological overview and survey of USA cannabis, cannabidiol and cannabinoid genotoxicity expressed in cancer incidence 2003-2017: part 1 - continuous bivariate analysis.
Reece AS; Hulse GK
Arch Public Health; 2022 Mar; 80(1):99. PubMed ID: 35354487
[TBL] [Abstract][Full Text] [Related]
6. Socioeconomic, Ethnocultural, Substance- and Cannabinoid-Related Epidemiology of Down Syndrome USA 1986-2016: Combined Geotemporospatial and Causal Inference Investigation.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293924
[TBL] [Abstract][Full Text] [Related]
7. Cannabis- and Substance-Related Epidemiological Patterns of Chromosomal Congenital Anomalies in Europe: Geospatiotemporal and Causal Inferential Study.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141481
[TBL] [Abstract][Full Text] [Related]
8. Contemporary epidemiology of rising atrial septal defect trends across USA 1991-2016: a combined ecological geospatiotemporal and causal inferential study.
Reece AS; Hulse GK
BMC Pediatr; 2020 Nov; 20(1):539. PubMed ID: 33250054
[TBL] [Abstract][Full Text] [Related]
9. Co-occurrence across time and space of drug- and cannabinoid- exposure and adverse mental health outcomes in the National Survey of Drug Use and Health: combined geotemporospatial and causal inference analysis.
Reece AS; Hulse GK
BMC Public Health; 2020 Nov; 20(1):1655. PubMed ID: 33148213
[TBL] [Abstract][Full Text] [Related]
10. Epidemiological association of cannabinoid- and drug- exposures and sociodemographic factors with limb reduction defects across USA 1989-2016: A geotemporospatial study.
Reece AS; Hulse GK
Spat Spatiotemporal Epidemiol; 2022 Jun; 41():100480. PubMed ID: 35691647
[TBL] [Abstract][Full Text] [Related]
11. Clinical Epigenomic Explanation of the Epidemiology of Cannabinoid Genotoxicity Manifesting as Transgenerational Teratogenesis, Cancerogenesis and Aging Acceleration.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834053
[TBL] [Abstract][Full Text] [Related]
12. Cannabinoid exposure as a major driver of pediatric acute lymphoid Leukaemia rates across the USA: combined geospatial, multiple imputation and causal inference study.
Reece AS; Hulse GK
BMC Cancer; 2021 Sep; 21(1):984. PubMed ID: 34479489
[TBL] [Abstract][Full Text] [Related]
13. European Epidemiological Patterns of Cannabis- and Substance-Related Congenital Neurological Anomalies: Geospatiotemporal and Causal Inferential Study.
Reece AS; Hulse GK
Int J Environ Res Public Health; 2022 Dec; 20(1):. PubMed ID: 36612763
[TBL] [Abstract][Full Text] [Related]
14. A geospatiotemporal and causal inference epidemiological exploration of substance and cannabinoid exposure as drivers of rising US pediatric cancer rates.
Reece AS; Hulse GK
BMC Cancer; 2021 Feb; 21(1):197. PubMed ID: 33632159
[TBL] [Abstract][Full Text] [Related]
15. Cannabis, Cannabinoids, and Brain Morphology: A Review of the Evidence.
Chye Y; Kirkham R; Lorenzetti V; McTavish E; Solowij N; Yücel M
Biol Psychiatry Cogn Neurosci Neuroimaging; 2021 Jun; 6(6):627-635. PubMed ID: 32948510
[TBL] [Abstract][Full Text] [Related]
16. Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development.
Reece AS; Hulse GK
Sci Rep; 2021 Jul; 11(1):13892. PubMed ID: 34230557
[TBL] [Abstract][Full Text] [Related]
17. Patterns of Cannabis- and Substance-Related Congenital General Anomalies in Europe: A Geospatiotemporal and Causal Inferential Study.
Reece AS; Hulse GK
Pediatr Rep; 2023 Feb; 15(1):69-118. PubMed ID: 36810339
[TBL] [Abstract][Full Text] [Related]
18. Use and Reported Helpfulness of Cannabinoids Among Primary Care Patients in Vermont.
Wershoven N; Kennedy AG; MacLean CD
J Prim Care Community Health; 2020; 11():2150132720946954. PubMed ID: 32757826
[No Abstract] [Full Text] [Related]
19. Congenital anomaly epidemiological correlates of Δ8THC across USA 2003-16: panel regression and causal inferential study.
Reece AS; Hulse GK
Environ Epigenet; 2022; 8(1):dvac012. PubMed ID: 35782486
[TBL] [Abstract][Full Text] [Related]
20. What does the ecological and epidemiological evidence indicate about the potential for cannabinoids to reduce opioid use and harms? A comprehensive review.
Campbell G; Hall W; Nielsen S
Int Rev Psychiatry; 2018 Oct; 30(5):91-106. PubMed ID: 30522342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
